T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS
10.2215/cjn.11941115
Saved in:
Main Authors: | CHAN CHANG YIEN, LIU DESHENG, ISAAC, Resontoc, Lourdes Paula, NG KAR HUI, CHAN YIONG HUAK, LAU YEW WENG PERRY, MYA THAN, Jordan C Stanley, LAM KONG PENG, YEO WEE SONG, YAP HUI KIM |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Article |
Language: | English |
Published: |
American Society of Nephrology
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/200316 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy
by: CHAN CHANG YIEN, et al.
Published: (2021) -
SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
by: Lu, Liangjian, et al.
Published: (2023) -
MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome
by: CHAN CHANG YIEN, et al.
Published: (2019) -
Interstitial pneumonitis : an unusual complication of rituximab
by: Udomsak Bunworasate, et al.
Published: (2008) -
Efficacy and safety of rituximab biosimilar in refractory lupus
by: Nantakarn Pongtarakulpanit, et al.
Published: (2020)